These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24925377)

  • 1. Amino acids and derivatives, a new treatment of chronic heart failure?
    Carubelli V; Castrini AI; Lazzarini V; Gheorghiade M; Metra M; Lombardi C
    Heart Fail Rev; 2015 Jan; 20(1):39-51. PubMed ID: 24925377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.
    Halbirk M; Nørrelund H; Møller N; Schmitz O; Gøtzsche L; Nielsen R; Nielsen-Kudsk JE; Nielsen SS; Nielsen TT; Eiskjær H; Bøtker HE; Wiggers H
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1220-5. PubMed ID: 20709866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure.
    Wu C; Kato TS; Ji R; Zizola C; Brunjes DL; Deng Y; Akashi H; Armstrong HF; Kennel PJ; Thomas T; Forman DE; Hall J; Chokshi A; Bartels MN; Mancini D; Seres D; Schulze PC
    Circ Heart Fail; 2015 Nov; 8(6):1077-87. PubMed ID: 26269566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure.
    Marazzi G; Rosanio S; Caminiti G; Dioguardi FS; Mercuro G
    Curr Pharm Des; 2008; 14(25):2592-604. PubMed ID: 18991676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Tao J; Liu X; Bai W
    Front Endocrinol (Lausanne); 2020; 11():110. PubMed ID: 32231640
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure.
    Aquilani R; Viglio S; Iadarola P; Opasich C; Testa A; Dioguardi FS; Pasini E
    Am J Cardiol; 2008 Jun; 101(11A):104E-110E. PubMed ID: 18514618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of taurine supplementation on exercise capacity of patients with heart failure.
    Beyranvand MR; Khalafi MK; Roshan VD; Choobineh S; Parsa SA; Piranfar MA
    J Cardiol; 2011 May; 57(3):333-7. PubMed ID: 21334852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamins in Heart Failure: Friend or Enemy?
    Georgiopoulos G; Chrysohoou C; Vogiatzi G; Magkas N; Bournelis I; Bampali S; Gruson D; Tousoulis D
    Curr Pharm Des; 2017; 23(25):3731-3742. PubMed ID: 28325140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation.
    Pineda-Juárez JA; Sánchez-Ortiz NA; Castillo-Martínez L; Orea-Tejeda A; Cervantes-Gaytán R; Keirns-Davis C; Pérez-Ocampo C; Quiroz-Bautista K; Tenorio-Dupont M; Ronquillo-Martínez A
    Clin Nutr; 2016 Feb; 35(1):41-47. PubMed ID: 25726428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 3-Month Astaxanthin Supplementation on Cardiac Function in Heart Failure Patients with Left Ventricular Systolic Dysfunction-A Pilot Study.
    Kato T; Kasai T; Sato A; Ishiwata S; Yatsu S; Matsumoto H; Shitara J; Murata A; Shimizu M; Suda S; Hiki M; Naito R; Daida H
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32604721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary nitrate supplementation and exercise tolerance in patients with heart failure with reduced ejection fraction.
    Hirai DM; Zelt JT; Jones JH; Castanhas LG; Bentley RF; Earle W; Staples P; Tschakovsky ME; McCans J; O'Donnell DE; Neder JA
    Am J Physiol Regul Integr Comp Physiol; 2017 Jan; 312(1):R13-R22. PubMed ID: 27784687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.
    Guazzi M; Myers J; Vicenzi M; Bensimhon D; Chase P; Pinkstaff S; Arena R
    Am Heart J; 2010 Nov; 160(5):900-5. PubMed ID: 21095278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
    Zile MR; Kjellstrom B; Bennett T; Cho Y; Baicu CF; Aaron MF; Abraham WT; Bourge RC; Kueffer FJ
    Circ Heart Fail; 2013 May; 6(3):508-16. PubMed ID: 23515277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failure.
    Shahzad K; Chokshi A; Schulze PC
    Curr Clin Pharmacol; 2011 Nov; 6(4):288-94. PubMed ID: 22082326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.
    Halbirk M; Nørrelund H; Møller N; Holst JJ; Schmitz O; Nielsen R; Nielsen-Kudsk JE; Nielsen SS; Nielsen TT; Eiskjaer H; Bøtker HE; Wiggers H
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1096-102. PubMed ID: 20081109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
    Santos-Gallego CG; Garcia-Ropero A; Mancini D; Pinney SP; Contreras JP; Fergus I; Abascal V; Moreno P; Atallah-Lajam F; Tamler R; Lala A; Sanz J; Fuster V; Badimon JJ
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):87-95. PubMed ID: 30675708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.
    Sung MM; Byrne NJ; Robertson IM; Kim TT; Samokhvalov V; Levasseur J; Soltys CL; Fung D; Tyreman N; Denou E; Jones KE; Seubert JM; Schertzer JD; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H842-H853. PubMed ID: 28159807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional assessment in heart failure patients.
    Lee JH; Jarreau T; Prasad A; Lavie C; O'Keefe J; Ventura H
    Congest Heart Fail; 2011; 17(4):199-203. PubMed ID: 21790970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Amino Acid Abnormalities in Chronic Heart Failure. Mechanisms, Potential Risks and Targets in Human Myocardium Metabolism.
    Aquilani R; La Rovere MT; Corbellini D; Pasini E; Verri M; Barbieri A; Condino AM; Boschi F
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29140312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.